Search - tctmd.com

Displaying 661 - 680 of 1192

Sort: Relevancy | Date

Presentation TCT 2016

Hypothermia and Cardiac Arrest: New Data on Patient Selection, Timing and Cooling Protocols

Presenter: Cindy L. Grines, Holger Thiele, David Erlinge

October 31, 2016

Presentation TCT 2016

LEADERS FREE: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Donald Cutlip

October 31, 2016

Presentation TCT 2016

Out-of-Hospital Cardiac Arrest: Who Benefits By an Immediate Invasive Strategy?

Presenter: Cindy L. Grines, Holger Thiele, Christian M. Spaulding

October 31, 2016

Presentation TCT 2016

Trial #3 - The Essentials of ... the LEADERS FREE trial

Presenter: Sunil V. Rao, Harvey D. White, Philip M. Urban

October 31, 2016

Presentation TCT 2016

MATRIX Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Frederick Feit

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO

Presenter: Simon R. Dixon, Holger Thiele, A. Reshad Garan

October 31, 2016

Presentation TCT 2016

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Presenter: Sunil V. Rao, Harvey D. White, Salvatore Brugaletta

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella

Presenter: Simon R. Dixon, Holger Thiele, Jerry D Estep

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP

Presenter: Simon R. Dixon, Holger Thiele, Susan M Joseph

October 31, 2016

Presentation TCT 2016

ABSORB III Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Ron Waksman

October 31, 2016

Presentation TCT 2016

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Presenter: Sunil V. Rao, Harvey D. White, Stephen G. Ellis

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock: Pathophysiology and Representative Case Presentation

Presenter: Simon R. Dixon, Holger Thiele, Ulrich P. Jorde

October 31, 2016

Presentation TCT 2016

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Presenter: Michael J. Cowley, Franz-Josef Neumann, Shunsuke Kubo

October 31, 2016

Presentation TCT 2016

TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With Bioresorbable Vascular Scaffolds for Acute Coronary Syndroms; Subgroup of the Prospective, All Comers, Controlled, Multicenter, FRANCE ABSORB Registry

Presenter: Michael J. Cowley, Franz-Josef Neumann, Joel Sainsous

October 31, 2016

Presentation TCT 2016

A Prospective, Randomized Trial of Impella vs Intra-aortic Balloon Counterpulsation in Patients with Cardiogenic Shock

Presenter: Thomas F. Luscher, Patrick W. Serruys, Jose P.S. Henriques

October 31, 2016

Presentation TCT 2016

TCT 50: Impact of a Bifurcation Culprit Lesion in ST Elevation Myocardial Infarction: Procedural Success, Clinical Outcome, and Five-Year Follow-up

Presenter: Michael J. Cowley, Franz-Josef Neumann, Pablo Salinas

October 31, 2016

Presentation TCT 2016

TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients

Presenter: Andreas Baumbach, Kurt Huber, Seiichi Hiramori

October 31, 2016

Presentation TCT 2016

TCT 3: Pretreatment With P2Y12 Receptor Antagonists Is Not Associated With Improved Patency of Infarct Related-Artery in STEMI A Report from SCAAR

Presenter: Andreas Baumbach, Kurt Huber, Elmir Omerovic

October 31, 2016

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

Presentation TCT 2016

TCT 1: Microvascular Obstruction Is Independently Associated With Adverse Events Following Primary PCI for STEMI: A Patient-Level Pooled Analysis from 7 Randomized Trials

Presenter: Andreas Baumbach, Kurt Huber, Andrea Abizaid, Jun-Jack Cheng, Rajiv Gulati, Jamil Abdalla Saad

October 31, 2016

Presentation TCT 2016

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

Presenter: Andreas Baumbach, Kurt Huber, Bjorn Redfors

October 31, 2016

Advertisement

Hypothermia and Cardiac Arrest: New Data on Patient Selection, Timing and Cooling Protocols

LEADERS FREE: Pros and Cons

Out-of-Hospital Cardiac Arrest: Who Benefits By an Immediate Invasive Strategy?

Trial #3 - The Essentials of ... the LEADERS FREE trial

MATRIX Critique: Pros and Cons

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella

Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP

ABSORB III Critique: Pros and Cons

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Acute Cardiogenic Shock: Pathophysiology and Representative Case Presentation

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With Bioresorbable Vascular Scaffolds for Acute Coronary Syndroms; Subgroup of the Prospective, All Comers, Controlled, Multicenter, FRANCE ABSORB Registry

A Prospective, Randomized Trial of Impella vs Intra-aortic Balloon Counterpulsation in Patients with Cardiogenic Shock

TCT 50: Impact of a Bifurcation Culprit Lesion in ST Elevation Myocardial Infarction: Procedural Success, Clinical Outcome, and Five-Year Follow-up

TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients

TCT 3: Pretreatment With P2Y12 Receptor Antagonists Is Not Associated With Improved Patency of Infarct Related-Artery in STEMI A Report from SCAAR

TCT 1: Microvascular Obstruction Is Independently Associated With Adverse Events Following Primary PCI for STEMI: A Patient-Level Pooled Analysis from 7 Randomized Trials

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content